Search results
Novavax's updated COVID-19 vaccine gets FDA approval
United Press International via Yahoo News· 7 months agoFederal regulators on Tuesday gave the go-ahead to an updated Novavax COVID-19 vaccine, giving Americans a more traditional alternative to two recently...
FDA Committee Proposes EUA Nod to Novavax's (NVAX) COVID Jab
Zacks via Yahoo Finance· 2 years agoAn FDA advisory committee supports granting emergency use authorization to Novavax's (NVAX) COVID-19...
FDA Authorizes Updated Novavax COVID-19 Vaccine
Verywell Health via Yahoo News· 7 months agoNovavax's updated COVID-19 vaccine is now authorized for U.S. teens and adults. The protein-based vaccine is the only immunization option that does not...
Changes to Novavax manufacturing data were minor and process related: Source
Yahoo Finance· 2 years agoNovavax's authorization timeline differs from other first-time applicants, and ongoing submission of...
The Zacks Analyst Blog Highlights Geron, Chemomab Therapeutics, Phathom Pharmaceuticals, Vera...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 6, 2023 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis...
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 25, 2023 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights Moderna, BioNTech, Novavax and Pfizer
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 23, 2023 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights Bristol Myers, Turning Point Therapeutics, Regeneron, Novavax, and...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – June 9, 2022 – Zacks.com announces the list of stocks featured...
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoNovavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript February 28, 2024 Novavax, Inc. misses...
Biotech Stock Roundup: NERV, RLMD Down on Updates, MRNA, NVAX's News & More
Zacks via Yahoo Finance· 2 years agoIt was a busy week for the volatile biotech sector, with important regulatory and pipeline updates...